{"id":"https://openalex.org/W2139377033","doi":"https://doi.org/10.1186/s12933-015-0279-z","title":"Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide study","display_name":"Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide study","publication_year":2015,"publication_date":"2015-09-03","ids":{"openalex":"https://openalex.org/W2139377033","doi":"https://doi.org/10.1186/s12933-015-0279-z","mag":"2139377033","pmid":"https://pubmed.ncbi.nlm.nih.gov/26338040","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4558893"},"language":"en","primary_location":{"id":"doi:10.1186/s12933-015-0279-z","doi":"https://doi.org/10.1186/s12933-015-0279-z","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12933-015-0279-z","pdf_url":"https://cardiab.biomedcentral.com/counter/pdf/10.1186/s12933-015-0279-z","source":{"id":"https://openalex.org/S12095120","display_name":"Cardiovascular Diabetology","issn_l":"1475-2840","issn":["1475-2840"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular Diabetology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://cardiab.biomedcentral.com/counter/pdf/10.1186/s12933-015-0279-z","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091908088","display_name":"Rafael Sim\u00f3","orcid":"https://orcid.org/0000-0003-0475-3096","observed_orcids":["https://orcid.org/0000-0003-0475-3096"]},"institutions":[{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210102407","display_name":"Vall d'Hebron Institut de Recerca","ror":"https://ror.org/01d5vx451","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210102407","https://openalex.org/I4387153040"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Rafael Sim\u00f3","raw_affiliation_strings":["CIREDEM, Carlos III Health Institute, Barcelona, Spain. rafael.simo@vhir.org","Diabetes Research and Metabolism Unit, Institut de Recerca Hospital Universitari Vall d'Hebron, Barcelona, Spain. rafael.simo@vhir.org"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CIREDEM, Carlos III Health Institute, Barcelona, Spain. rafael.simo@vhir.org","institution_ids":["https://openalex.org/I2801357902"]},{"raw_affiliation_string":"Diabetes Research and Metabolism Unit, Institut de Recerca Hospital Universitari Vall d'Hebron, Barcelona, Spain. rafael.simo@vhir.org","institution_ids":["https://openalex.org/I4210102407","https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064287355","display_name":"Bruno Guerci","orcid":"https://orcid.org/0000-0002-6211-464X","observed_orcids":["https://orcid.org/0000-0002-6211-464X"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210100260","display_name":"Centre Hospitalier R\u00e9gional et Universitaire de Nancy","ror":"https://ror.org/016ncsr12","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100260"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Bruno Guerci","raw_affiliation_strings":["Diabetologie, Maladies Metaboliques and Nutrition, H\u00f4pital Brabois, CHU de Nancy, et CIC Inserm, Vandoeuvre L\u00e8s Nancy, France. b.guerci@chu-nancy.fr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diabetologie, Maladies Metaboliques and Nutrition, H\u00f4pital Brabois, CHU de Nancy, et CIC Inserm, Vandoeuvre L\u00e8s Nancy, France. b.guerci@chu-nancy.fr","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210100260"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048027389","display_name":"Guntram Schernthaner","orcid":"https://orcid.org/0000-0003-2397-4468","observed_orcids":["https://orcid.org/0000-0003-2397-4468"]},"institutions":[{"id":"https://openalex.org/I4210111069","display_name":"Krankenanstalt Rudolfstiftung der Stadt Wien","ror":"https://ror.org/019myg640","country_code":"AT","type":"healthcare","lineage":["https://openalex.org/I4210111069","https://openalex.org/I4210117134"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Guntram Schernthaner","raw_affiliation_strings":["Rudolfstiftung Hospital-Vienna, Vienna, Austria. guntram.schernthaner@meduniwien.ac.at"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rudolfstiftung Hospital-Vienna, Vienna, Austria. guntram.schernthaner@meduniwien.ac.at","institution_ids":["https://openalex.org/I4210111069"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105783630","display_name":"Baptist Gallwitz","orcid":"https://orcid.org/0000-0002-8880-6409","observed_orcids":["https://orcid.org/0000-0002-8880-6409"]},"institutions":[{"id":"https://openalex.org/I4210094118","display_name":"Universit\u00e4tsklinikum T\u00fcbingen","ror":"https://ror.org/00pjgxh97","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210094118"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Baptist Gallwitz","raw_affiliation_strings":["Medizinische Klinik IV, Universit\u00e4tsklinikum T\u00fcbingen, T\u00fcbingen, Germany. baptist.gallwitz@med.uni-tuebingen.de"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medizinische Klinik IV, Universit\u00e4tsklinikum T\u00fcbingen, T\u00fcbingen, Germany. baptist.gallwitz@med.uni-tuebingen.de","institution_ids":["https://openalex.org/I4210094118"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012267309","display_name":"Juan Rosas-Guzm\u00e1n","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Juan Rosas-Guzm\u00e0n","raw_affiliation_strings":["Celaya Center for Specialist Medicine, Celaya, Guanajuato, Mexico. jrosas@att.net.mx"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celaya Center for Specialist Medicine, Celaya, Guanajuato, Mexico. jrosas@att.net.mx","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069364785","display_name":"Francesco Dotta","orcid":"https://orcid.org/0000-0003-4947-7478","observed_orcids":["https://orcid.org/0000-0003-4947-7478"]},"institutions":[{"id":"https://openalex.org/I102064193","display_name":"University of Siena","ror":"https://ror.org/01tevnk56","country_code":"IT","type":"education","lineage":["https://openalex.org/I102064193"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Francesco Dotta","raw_affiliation_strings":["Diabetes Unit, Policlinico Le Scotte, University of Siena, Siena, Italy. francesco.dotta@alice.it"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diabetes Unit, Policlinico Le Scotte, University of Siena, Siena, Italy. francesco.dotta@alice.it","institution_ids":["https://openalex.org/I102064193"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111922692","display_name":"Andreas Festa","orcid":"https://orcid.org/0009-0009-4278-2964","observed_orcids":["https://orcid.org/0009-0009-4278-2964"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andreas Festa","raw_affiliation_strings":["Eli Lilly and Company, Eli Lilly Regional Operations Ges.m.b.H., Vienna, Austria. festa_andreas@lilly.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Eli Lilly Regional Operations Ges.m.b.H., Vienna, Austria. festa_andreas@lilly.com","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042646731","display_name":"Ming Zhou","orcid":"https://orcid.org/0000-0003-4101-3185","observed_orcids":["https://orcid.org/0000-0003-4101-3185"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ming Zhou","raw_affiliation_strings":["Bristol-Myers Squibb, Pennington, NJ, USA. ming.zhou@bms.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Pennington, NJ, USA. ming.zhou@bms.com","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021409500","display_name":"Jacek I. Kiljanski","orcid":"https://orcid.org/0000-0003-0354-0558","observed_orcids":["https://orcid.org/0000-0003-0354-0558"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jacek Kilja\u0144ski","raw_affiliation_strings":["Eli Lilly, Eli Lilly and Company, Eli Lilly Polska Sp. z o.o., Warsaw, Poland. kiljanski_jacek@lilly.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly, Eli Lilly and Company, Eli Lilly Polska Sp. z o.o., Warsaw, Poland. kiljanski_jacek@lilly.com","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5091908088"],"corresponding_institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210102407","https://openalex.org/I4210127641"],"apc_list":{"value":4290,"currency":"USD","value_usd":4290},"apc_paid":{"value":4290,"currency":"USD","value_usd":4290},"fwci":5.9304,"has_fulltext":true,"cited_by_count":47,"citation_normalized_percentile":{"value":0.97161168,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"14","issue":"1","first_page":"116","last_page":"116"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":0.890999972820282},{"id":"https://openalex.org/keywords/glimepiride","display_name":"glimepiride","score":0.9900000095367432},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9919999837875366},{"id":"https://openalex.org/keywords/cardiovascular-risk-markers","display_name":"cardiovascular risk markers","score":0.8610000014305115},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9100000262260437},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":0.984000027179718},{"id":"https://openalex.org/keywords/metformin-add-on-therapy","display_name":"metformin add-on therapy","score":0.8569999933242798},{"id":"https://openalex.org/keywords/high-sensitivity-c-reactive-protein","display_name":"high-sensitivity C-reactive protein","score":0.8450000286102295},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.7860000133514404},{"id":"https://openalex.org/keywords/lipids","display_name":"lipids","score":0.5860000252723694},{"id":"https://openalex.org/keywords/body-weight","display_name":"body weight","score":0.703000009059906},{"id":"https://openalex.org/keywords/waist-circumference","display_name":"waist circumference","score":0.8119999766349792},{"id":"https://openalex.org/keywords/hdl-cholesterol","display_name":"HDL cholesterol","score":0.8980000019073486},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.8830000162124634},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.7020000219345093},{"id":"https://openalex.org/keywords/heart-rate","display_name":"heart rate","score":0.6520000100135803},{"id":"https://openalex.org/keywords/antihypertensive-drugs","display_name":"antihypertensive drugs","score":0.8130000233650208}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.887030839920044},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.8595799803733826},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.792397141456604},{"id":"https://openalex.org/C2776307423","wikidata":"https://www.wikidata.org/wiki/Q425027","display_name":"Glimepiride","level":4,"score":0.7877273559570312},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6343827247619629},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5625247955322266},{"id":"https://openalex.org/C2778854520","wikidata":"https://www.wikidata.org/wiki/Q418776","display_name":"Sulfonylurea","level":3,"score":0.5446673035621643},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.5085834264755249},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.5072636008262634},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.48435720801353455}],"mesh":[{"descriptor_ui":"D000077270","descriptor_name":"Exenatide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002097","descriptor_name":"C-Reactive Protein","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005060","descriptor_name":"Europe","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006339","descriptor_name":"Heart Rate","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008055","descriptor_name":"Lipids","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013453","descriptor_name":"Sulfonylurea Compounds","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D013453","descriptor_name":"Sulfonylurea Compounds","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054795","descriptor_name":"Incretins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D054795","descriptor_name":"Incretins","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1186/s12933-015-0279-z","doi":"https://doi.org/10.1186/s12933-015-0279-z","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12933-015-0279-z","pdf_url":"https://cardiab.biomedcentral.com/counter/pdf/10.1186/s12933-015-0279-z","source":{"id":"https://openalex.org/S12095120","display_name":"Cardiovascular Diabetology","issn_l":"1475-2840","issn":["1475-2840"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular Diabetology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4558893","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4558893","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovasc Diabetol","raw_type":"Text"},{"id":"pmid:26338040","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26338040","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular diabetology","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.790.142","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.790.142","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/f9/de/12933_2015_Article_279.PMC4558893.pdf","raw_type":"text"},{"id":"pmh:oai:usiena-air.unisi.it:11365/982264","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11365/982264","pdf_url":null,"source":{"id":"https://openalex.org/S4377196319","display_name":"Use Siena air (University of Siena)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I102064193","host_organization_name":"University of Siena","host_organization_lineage":["https://openalex.org/I102064193"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1186/s12933-015-0279-z","doi":"https://doi.org/10.1186/s12933-015-0279-z","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12933-015-0279-z","pdf_url":"https://cardiab.biomedcentral.com/counter/pdf/10.1186/s12933-015-0279-z","source":{"id":"https://openalex.org/S12095120","display_name":"Cardiovascular Diabetology","issn_l":"1475-2840","issn":["1475-2840"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular Diabetology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307768","display_name":"Amylin Pharmaceuticals","ror":"https://ror.org/043cec594"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2139377033.pdf","grobid_xml":"https://content.openalex.org/works/W2139377033.grobid-xml"},"referenced_works_count":62,"referenced_works":["https://openalex.org/W22189248","https://openalex.org/W47644979","https://openalex.org/W1483014275","https://openalex.org/W1545732697","https://openalex.org/W1563830789","https://openalex.org/W1941032944","https://openalex.org/W1971997087","https://openalex.org/W1985743763","https://openalex.org/W1987538170","https://openalex.org/W2011499650","https://openalex.org/W2012506661","https://openalex.org/W2012689879","https://openalex.org/W2014663082","https://openalex.org/W2027276740","https://openalex.org/W2027686692","https://openalex.org/W2030757778","https://openalex.org/W2036538757","https://openalex.org/W2045748945","https://openalex.org/W2050040011","https://openalex.org/W2058239977","https://openalex.org/W2059158127","https://openalex.org/W2062511741","https://openalex.org/W2070710390","https://openalex.org/W2087345181","https://openalex.org/W2091836518","https://openalex.org/W2092371224","https://openalex.org/W2093104618","https://openalex.org/W2093738306","https://openalex.org/W2097848179","https://openalex.org/W2098459806","https://openalex.org/W2101297052","https://openalex.org/W2102211240","https://openalex.org/W2102899779","https://openalex.org/W2107222124","https://openalex.org/W2107562831","https://openalex.org/W2111628328","https://openalex.org/W2111876001","https://openalex.org/W2115692972","https://openalex.org/W2124977666","https://openalex.org/W2128243640","https://openalex.org/W2133416234","https://openalex.org/W2137408480","https://openalex.org/W2139203772","https://openalex.org/W2142400535","https://openalex.org/W2143954917","https://openalex.org/W2155234088","https://openalex.org/W2157002690","https://openalex.org/W2157869836","https://openalex.org/W2158778171","https://openalex.org/W2160088494","https://openalex.org/W2165465852","https://openalex.org/W2167557672","https://openalex.org/W2171294019","https://openalex.org/W2171646682","https://openalex.org/W2188846692","https://openalex.org/W2190748907","https://openalex.org/W2599408064","https://openalex.org/W2607031541","https://openalex.org/W3198570063","https://openalex.org/W4205288846","https://openalex.org/W4242364069","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W7098758921","https://openalex.org/W2522021563","https://openalex.org/W2042734203","https://openalex.org/W2158290990","https://openalex.org/W2093104618","https://openalex.org/W2142400535","https://openalex.org/W2145153887","https://openalex.org/W3038103931","https://openalex.org/W3147185284","https://openalex.org/W2009551415"],"abstract_inverted_index":{"OBJECTIVE:":[0],"The":[1],"risk":[2,26,32,252],"of":[3,174,218],"cardiovascular":[4,31,251],"morbidity":[5],"and":[6,106,145,156,161,201],"mortality":[7],"is":[8,17],"significantly":[9,171],"increased":[10,166],"in":[11,30,36,59,172,249,254],"patients":[12,37,207,255],"with":[13,38,43,70,123,245,256],"diabetes;":[14],"thus,":[15],"it":[16],"important":[18],"to":[19,57,78,209],"determine":[20],"whether":[21],"glucose-lowering":[22],"therapy":[23],"affects":[24],"this":[25],"over":[27,111],"time.":[28],"Changes":[29],"markers":[33,253],"were":[34,76,113,170],"examined":[35],"type":[39,71,257],"2":[40,72,258],"diabetes":[41,73,259],"treated":[42],"exenatide":[44,80,120,175,210,240],"twice":[45,81,211,241],"daily":[46,82,212,242],"(a":[47,54],"glucagon-like":[48],"peptide-1":[49],"receptor":[50],"agonist)":[51],"or":[52,86,229],"glimepiride":[53,87,214],"sulfonylurea)":[55],"added":[56],"metformin":[58,75],"the":[60,216],"EURopean":[61],"EXenAtide":[62],"(EUREXA)":[63],"study.":[64],"RESEARCH":[65],"DESIGN":[66],"AND":[67],"METHODS:":[68],"Patients":[69],"failing":[74],"randomized":[77,208],"add-on":[79],"(n":[83,88],"=":[84,89,195,199,204,227,236],"515)":[85],"514)":[90],"until":[91],"treatment":[92],"failure":[93],"defined":[94],"by":[95],"hemoglobin":[96],"A1C.":[97],"Anthropomorphic":[98],"measures,":[99],"blood":[100],"pressure":[101],"(BP),":[102],"heart":[103],"rate,":[104],"lipids,":[105],"high-sensitivity":[107],"C-reactive":[108],"protein":[109],"(hsCRP)":[110],"time":[112],"evaluated.":[114],"RESULTS:":[115],"Over":[116],"36":[117],"months,":[118],"twice-daily":[119],"was":[121,243],"associated":[122,244],"improved":[124],"body":[125,177],"weight":[126,178],"(-3.9":[127],"kg),":[128],"waist":[129,182],"circumference":[130,183],"(-3.6":[131],"cm),":[132],"systolic/diastolic":[133],"BP":[134,188,193],"(-2.5/-2.6":[135],"mmHg),":[136],"high-density":[137],"lipoprotein":[138],"(HDL)-cholesterol":[139],"(0.05":[140],"mmol/L),":[141,144],"triglycerides":[142],"(-0.2":[143],"hsCRP":[146,202],"(-1.7":[147],"mg/L).":[148],"Heart":[149],"rate":[150],"did":[151],"not":[152],"increase":[153],"(-0.3":[154],"beats/minute),":[155],"low-density":[157],"lipoprotein-cholesterol":[158],"(0.2":[159],"mmol/L)":[160,165],"total":[162],"cholesterol":[163],"(0.1":[164],"slightly.":[167],"Between-group":[168],"differences":[169],"favor":[173],"for":[176],"(P":[179,184,189,194,198,203],"<":[180,185,190],"0.0001),":[181],"0.001),":[186,191,200],"systolic":[187],"diastolic":[192],"0.023),":[196],"HDL-cholesterol":[197],"0.004).":[205],"Fewer":[206],"versus":[213,260],"required":[215],"addition":[217],"at":[219],"least":[220],"one":[221],"antihypertensive":[222],"(20.4":[223],"vs":[224,233],"26.4%;":[225],"P":[226,235],"0.026)":[228],"lipid-lowering":[230],"medication":[231],"(8.4":[232],"12.8%;":[234],"0.025).":[237],"CONCLUSIONS:":[238],"Add-on":[239],"significant,":[246],"sustained":[247],"improvement":[248],"several":[250],"glimepiride.":[261],"CLINICAL":[262],"TRIAL":[263],"REGISTRATION:":[264],"NCT00359762,":[265],"http://www.ClinicalTrials.gov.":[266]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":14},{"year":2016,"cited_by_count":6}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}